延髓胶质瘤术后短期下组颅神经功能障碍评估系统:风险分层与最佳手术策略
本研究基于回顾性队列(n=111)开发并前瞻性验证(n=45)延髓胶质瘤术后短期下组颅神经功能障碍的个体化预测模型,识别出EOR、浸润性生长、术前LCN损伤和颈髓受累四个独立预测因子,模型区分度良好(测试AUC 0.89),并据此提出基于风险分层的动态切除策略。
要点
- 四个独立预测因子:EOR(OR 1.84)、浸润性生长(OR 10.46)、术前LCN损伤(OR 6.79)、颈髓受累(OR 4.64)。
- 高风险阈值0.471,高风险患者肺炎、气管切开和机械通气延长发生率显著更高。
- 低风险患者推荐全切除(EOR 88.4%),高风险患者局限切除(EOR 40.8%)获最佳功能结局。
核心结论
- 首次构建针对延髓胶质瘤术后短期下组颅神经结局的预测模型,提出基于个体化风险分层的动态切除范式。
研究设计与样本
- 回顾性队列(n=111,2020年1月至2023年2月)用于模型开发,前瞻性验证(n=45,2023年2月至2024年12月)。
- 采用逻辑回归建模,纳入多阶段特征选择、超参数优化和自助法验证。
- 主要结局为术后LCN功能障碍(14天内无法拔管或需气管切开持续通气)。
主要发现
- EOR(OR 1.84,95%CI 1.07-3.16)、浸润性生长(OR 10.46,95%CI 2.70-40.52)、术前LCN损伤(OR 6.79,95%CI 2.54-18.16)、颈髓受累(OR 4.64,95%CI 1.55-13.91)为独立预测因子。
- 模型训练AUC 0.85(95%CI 0.76-0.92),测试AUC 0.89(95%CI 0.79-0.97),Brier评分0.12。
- 基于Youden指数的高风险阈值为预测风险概率>0.471,高风险患者肺炎、气管切开和机械通气延长发生率显著更高。
- 低风险患者全切除(EOR 88.4%,95%CI 75.7%-100.0%)获益,高风险患者局限切除(EOR 40.8%,95%CI 38.2%-50.5%)获最佳功能结局。
关键数值与推荐
- 高风险定义为模型预测风险概率>0.471(基于Youden指数)。
- 低风险患者推荐全切除(EOR 88.4%,95%CI 75.7%-100.0%)。
- 高风险患者推荐局限切除(EOR 40.8%,95%CI 38.2%-50.5%)。
临床怎么用
- 利用列线图进行术前风险咨询和个体化手术规划。
- 根据预测风险动态调整切除范围,平衡肿瘤控制与功能保留。
- 高风险患者术中可考虑更保守的切除策略以降低LCN功能障碍风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Medullary gliomas pose significant surgical risks, particularly the risk of postoperative lower cranial nerve (LCN) dysfunction, which profoundly affects quality of life. The lack of standardized risk assessment hinders optimal surgical planning. The aim of this study was to develop and validate an individualized predictive model for short-term postoperative LCN impairment integrating clinical and imaging data and to estimate individual risk across a range of resection extent to optimize surgical planning. METHODS: A retrospective cohort (n = 111, January 2020-February 2023) was used for model development, with prospective validation (n = 45, February 2023-December 2024). The primary outcome was postoperative LCN dysfunction (inability to be extubated within 14 days or requiring tracheotomy with persistent ventilation). Predictive modeling was performed using logistic regression, incorporating multistage feature selection, hyperparameter optimization, and bootstrapped validation. Model performance was evaluated using metrics such as area under the curve (AUC), Brier score, calibration, and decision curve analysis (DCA) in the prospective validation set. Shapley Additive Explanations (SHAP) analysis was used to interpret feature contributions, and a nomogram was constructed for clinical implementation. Optimal extent of resection (EOR) thresholds were explored to balance functional preservation and tumor clearance. RESULTS: Four independent predictors of LCN dysfunction were identified: EOR (OR 1.84, 95% CI 1.07-3.16), infiltrative growth (OR 10.46 [95% CI 2.70-40.52]), preoperative LCN impairment (OR 6.79 [95% CI 2.54-18.16]), and cervical cord involvement (OR 4.64 [95% CI 1.55-13.91]). The model demonstrated strong discrimination (training AUC 0.85 [95% CI 0.76-0.92], testing AUC 0.89 [95% CI 0.79-0.97]) and good calibration (Brier score 0.12). High-risk patients, defined as those with a model predicted risk probability > 0.471 based on Youden's index, had significantly higher rates of pneumonia, tracheostomy, and prolonged mechanical ventilation. Stratified resection plans showed that low-risk patients benefited from gross-total resection (EOR 88.4%, [95% CI 75.7%-100.0%]), while high-risk patients achieved optimal functional outcomes with limited resection (EOR 40.8%, [95% CI 38.2%-50.5%]). SHAP and nomogram analyses provided transparent, patient-specific information for risk consultations. CONCLUSIONS: This study presents the first predictive model tailored to short-term postoperative LCN outcomes following medullary glioma surgery, proposing a dynamic resection paradigm based on individualized risk stratification. By guiding surgical planning and intraoperative decision-making, this model facilitates a balance between maximal tumor control and functional preservation.
引用
- Zhang M, Xiao X, Jia H, et al. Assessment system for short-term lower cranial nerve dysfunction following medulla oblongata glioma surgery: risk stratification and optimal surgical strategy. J Neurosurg. 2026. PMID: 42214095. doi:10.3171/2025.12.JNS251593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。